Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
303 Leser
Artikel bewerten:
(1)

Altcoinist: $1.5M Raised by Bitcoin.com Co-founder and ETH Dev to Revolutionize Creator Monetization

Finanznachrichten News

Altcoinist is developing an on-chain subscription tool as a monetization solution for creator economies.

DUBAI, UAE / ACCESSWIRE / July 5, 2024 / Altcoinist, an on-chain gateway giving creators a new way to monetize and grow private communities, has successfully completed its pre-seed and initial seed round of financing, raising over $1.5M. Their Seed A round is led by EnigmaFund, a prominent venture capital firm known for its investments in web3 startups including SuperChain, Movement Labs, ATOR, Ready Games, Entangle Protocol, ZeroLend, and more.

On-Chain Solution For Creator Economies

Altcoinist aims to solve the broken monetization issue of the creator economy by introducing a seamless tool for creators to earn through forming private communities. Their solution leverages on-chain subscriptions for creators, ensuring stable revenue streams while also facilitating automated revenue sharing between the creator and their community. This novel approach merges the proven monetization model of recurring payments with web3, while creators can enjoy increased earnings and retention within their community.

Silur, Lead Developer at Altcoinist, emphasized the potential of Altcoinist:

"Altcoinist is an interoperable tool creators can use to monetize that also acts as an engine fueling further growth, benefiting both the creator and their community, all powered by smart contract"

Backed By Experience

The core team at Altcoinist includes Christian Andsberg, Mate Tokay, Silur (Abraham Endre) and Konstantin Sebeo. Serial founders with impressive backgrounds in the web3 space. Mate founded Bitcoinist.com and co-founded Bitcoin.com, while Silur, a Forbes 30 under 30 honoree and Ethereum core developer, has delivered contributions to over 50 projects including Monero and Casper Labs. Their extensive experience includes building platforms that have onboarded over 40 million users to Web3.

Konstantin, Head of Research and Creator, stated:

"We've built a unique product empowering creators to set up their first business (a private community) in under a minute and start making on-chain recurring income. With us, everyone finally gets a fair chance at making a significant and sustainable living from value-based content"

Strong Early Interest

Altcoinist has already attracted dozens of creators supporting the project and garnered over 55 million organic impressions on Twitter/X this year. EnigmaFund's involvement in Altcoinist's Seed A round is a significant endorsement of their vision and potential. The fund is renowned for backing and advising projects that push the boundaries of blockchain technology:

"Our investment and partnership will enable Altcoinist to accelerate its development and bring its innovative solutions to a wider audience."

In addition to EnigmaFund, Altcoinist has seen participation from other notable firms including AlphaCrypto Capital, Explore Capital, Crypto Society, MoonbootsDAO, and Excelsior.

Altcoinist is also supported by a distinguished group of backers and advisors, including Theodore Agranat (Advisor of Gunzilla Games, Movement Labs, Gaimin), Rich Robinson (Entrepreneur in Residence at Animoca Brands), Thomas McLeod (5x founder with exits to Coinbase, SurrealCMS, and Tencent), Aleksander Rendtslev (4x founder with ventures backed by a16z and General Catalyst), Austin Seiberlich (Advisor of Entangle, Superchain, Ready Games, ZeroLend), and Coco (Founder of TOSHI).

Altcoinist's CEO, Christian Andsberg, expressed excitement about the partnership with EnigmaFund, stating:

"We are thrilled to have EnigmaFund lead our round and join our advisory board. Their expertise and support will be invaluable as we're paving the way for a more evolved creator economy."

Future Outlook & Seed B Round

Having designed a platform that enhances user value and ecosystem value as it scales, Altcoinist is poised to become a key player in the creator economy as they grow. Their unique focus on simple user deployment while abstracting the complexity of smart contracts sets them apart as a leader in the rapidly evolving space of web3. Altcoinist is now raising a follow-on Seed B round to aid their go-to-market efforts. The platform is built on Base chain, ensuring a robust and scalable EVM infrastructure.

For more information about Altcoinist and its upcoming developments, follow them on x.com.

Media Contact:

Contact Name: Christian Andsberg
Contact Email: info@altcoinist.com

Altcoinist is the source of this content. This Press Release is for informational purposes only. The information does not constitute investment advice or an offer to invest.

SOURCE: Altcoinist



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.